Florian Lordick/LinkedIn
Feb 20, 2025, 08:59
Florian Lordick: Esopec is now a practice-changing trial
Florian Lordick, Oncologist, Professor of Medicine at the University of Leipzig, shared a post on LinkedIn about a paper by Jens Hoeppner et al. published in NEJM:
“Esopec is now a practice-changing trial. Update of ESMO – European Society for Medical Oncology’s Esophageal Cancer guidelines just published in ESMO Open. Congratulations to Radka Obermannová and the ESMO – European Society for Medical Oncology guidelines committee.”
“Perioperative Chemotherapy or Preoperative Chemoradiotherapy in Esophageal Cancer”
Authors: Jens Hoeppner et al.
More posts featuring Florian Lordick.
-
Challenging the Status Quo in Colorectal Cancer 2024
December 6-8, 2024
-
ESMO 2024 Congress
September 13-17, 2024
-
ASCO Annual Meeting
May 30 - June 4, 2024
-
Yvonne Award 2024
May 31, 2024
-
OncoThon 2024, Online
Feb. 15, 2024
-
Global Summit on War & Cancer 2023, Online
Dec. 14-16, 2023
Jun 8, 2025, 17:03
Jun 8, 2025, 16:53